Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease

Objective We assessed the curative effect of a second curettage in patients with persistent hCG serum levels after first for gestational trophoblastic disease (GTD). Study Design This prospective observational study used data Belgian register GTD between July 2012 and January 2017. analysed who underwent curettage. included 313 database. Primary endpoints were need chemotherapy. Results Thirty-seven population (12 %) 20 had human chorionic gonadotropin hormone (hCG) elevation before Of them, 9 (45 needed no further treatment afterwards. Eleven (55 Nine (82 cured single-agent chemotherapy 2 (18 multi-agent 37 patients, below 5000 IU/L undergoing without 65 % versus 45 level more than IU/L. ten 1000 IU/L, eight Conclusions Patients post-mole neoplasia can benefit from to avoid chemotherapy, especially when is lower